FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1208591008: Product containing precisely oseltamivir (as oseltamivir phosphate) 30 milligram/1 each conventional release oral capsule (clinical drug)


Status: current, Defined. Date: 31-Mar 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4965186012 Oseltamivir (as oseltamivir phosphate) 30 mg oral capsule en Synonym Active Case insensitive SNOMED CT core
4965187015 Product containing precisely oseltamivir (as oseltamivir phosphate) 30 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oseltamivir (as oseltamivir phosphate) 30 mg oral capsule Is a Oseltamivir only product in oral dose form true Inferred relationship Some
Oseltamivir (as oseltamivir phosphate) 30 mg oral capsule Has manufactured dose form Conventional release oral capsule true Inferred relationship Some
Oseltamivir (as oseltamivir phosphate) 30 mg oral capsule Has unit of presentation Capsule true Inferred relationship Some
Oseltamivir (as oseltamivir phosphate) 30 mg oral capsule Plays role Antiviral therapeutic role true Inferred relationship Some
Oseltamivir (as oseltamivir phosphate) 30 mg oral capsule Has precise active ingredient Oseltamivir phosphate true Inferred relationship Some 1
Oseltamivir (as oseltamivir phosphate) 30 mg oral capsule Has BoSS Oseltamivir true Inferred relationship Some 1
Oseltamivir (as oseltamivir phosphate) 30 mg oral capsule Has presentation strength numerator unit mg true Inferred relationship Some 1
Oseltamivir (as oseltamivir phosphate) 30 mg oral capsule Has presentation strength denominator unit Capsule true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start